某净水公司职工脂肪肝检出情况及影响因素分析

doi:10.20223/j.cnki.1000-8535.2024.12.011

广州医药 ›› 2024, Vol. 55 ›› Issue (12): 1456-1463.DOI: 10.20223/j.cnki.1000-8535.2024.12.011

某净水公司职工脂肪肝检出情况及影响因素分析

吴琼¹, 宋慧东¹, 汤永翔¹, 肖清华¹, 吴彩平¹, 吴坚坚^2,3

1 广州市第十二人民医院职业健康监护中心（广东广州 510620）
2 中山大学附属第六医院泌尿外科（广东广州 510655）
3 广州市黄埔区中六生物医学创新研究院（广东广州 510799）

收稿日期:2024-07-18 出版日期:2024-12-20 发布日期:2025-01-08
通讯作者: 吴坚坚,E-mail：wujj235@mail.sysu.edu.cn
基金资助:
广州市科技计划项目（2023A03J0493）

Prevalence of fatty liver disease and influencing factors among employees in a water purification company

WU Qiong¹, SONG Huidong¹, TANG Yongxiang, XIAO Qinghua¹, WU Caiping¹, WU Jianjian^2,3

1 Occupational Health Surveillance Center, Guangzhou Twelfth People's Hospital, Guangzhou 510620, China
2 Department of Urology, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou 510655, China
3 Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou 510799, China

Received:2024-07-18 Online:2024-12-20 Published:2025-01-08

摘要/Abstract

摘要： 目的了解广州市某净水公司职工脂肪肝检出情况,并分析影响因素。方法选取2023年广州市某净水公司参加职业健康检查的职工为研究对象,收集研究对象的一般情况、个人史、职业史、身体质量指数（BMI）、血压、血生化指标、肝脏彩超等资料。对该人群脂肪肝的患病情况进行描述性分析,对脂肪肝的影响因素进行单因素及多因素Logistic回归分析。结果共收集研究对象1 217人,检出脂肪肝543例,检出率为44.62%。单因素分析结果表明,脂肪肝的发生与性别、年龄、体质量指数、高血压相关（P<0.05）。接触硫化氢、氨的职工脂肪肝检出率高于非接触者（P<0.05）,且职工工龄越长,脂肪肝检出率越高（P<0.05）。患脂肪肝职工的肝功能、脂代谢、血糖及尿酸水平高于非脂肪肝者（P<0.05）。多因素Logistic回归分析提示,年龄、体质量指数、肝功能异常、脂代谢异常、高血糖、高尿酸是脂肪肝的影响因素（P<0.05）。结论广州市某净水公司职工的脂肪肝检出率较高,脂肪肝的发生主要与年龄、体质量指数、肝功能异常、脂代谢异常、高血糖、高尿酸等因素相关。

关键词: 净水公司, 脂肪肝, 影响因素, 职业危害因素

Abstract: Objective To investigate the prevalence of fatty liver disease and influencing factors among employees of a water purification company in Guangzhou．Methods Employees of a water purification company in Guangzhou who participated in occupational health examinations in 2023 were selected as the study subjects．The subjects' general conditions,personal history,occupational history,BMI,blood pressure,blood biochemical indicators,and liver ultrasound images were collected．Descriptive analysis was used to analyze the prevalence of fatty liver disease in this population．The influencing factors of fatty liver were analyzed by single factor and multiple factor Logistic regression．Results A total of 1 217 subjects were included in this study,and 543 were diagnosed as fatty liver disease,with a detection rate of 44.62%．The results of single factor analysis showed that the occurrence of fatty liver was closely related to gender,age,BMI and hypertension（P<0.05）．The analysis of occupational hazard factors showed that,the detection rate of fatty liver disease was higher in people exposed to hydrogen sulfide and ammonia compared to non-exposed individuals（P<0.05）．The longer the working years,the higher the detection rate of fatty liver（P<0.05）．The levels of liver function,lipid metabolism,blood glucose and uric acid in workers with fatty liver were higher than those in workers without fatty liver（P<0.05）．Multivariate Logistic regression analysis showed that age,BMI,abnormal liver function,abnormal lipid metabolism,high blood glucose levels and hyperuricemia were independent influencing factors for fatty liver disease（P<0.05）．Conclusions The detection rate of fatty liver disease among employees of a water purification company in Guangzhou is high,and the occurrence of fatty liver disease is mainly related to factors such as age,BMI,abnormal liver function,abnormal lipid metabolism,high sugar levels and hyperuricemia．

Key words: water purification company, fatty liver disease, influencing factors, occupational hazard factors

吴琼, 宋慧东, 汤永翔, 肖清华, 吴彩平, 吴坚坚. 某净水公司职工脂肪肝检出情况及影响因素分析[J]. 广州医药, 2024, 55(12): 1456-1463.

WU Qiong, SONG Huidong, TANG Yongxiang, XIAO Qinghua, WU Caiping, WU Jianjian. Prevalence of fatty liver disease and influencing factors among employees in a water purification company[J]. Guangzhou Medical Journal, 2024, 55(12): 1456-1463.

参考文献

[1] 严磊,李杰,李萌,等.昆明市体检人群脂肪肝患病率及危险因素分析[J].华南预防医学,2023,49(11):1427-1430.
[2] WONG V W,WONG G L,WOO J,et al.Impact of the new definition of metabolic associated fatty liver disease on the epidemiology of the disease[J].Clin Gastroenterol Hepatol,2021,19(10):2161-2171.
[3] MEI E H,YAO C,CHEN Y N,et al.Multifunctional role of oral bacteria in the progression of non-alcoholic fatty liver disease[J].World J Hepatol,2024,16(5):688-702.
[4] 李萍,刘白灵,冼彩连,等.非酒精性脂肪肝患者昼夜节律特点及相关因素分析[J].广州医药,2020,51(4):85-88.
[5] GONZÁLEZ-RIVERA A,VARGAS-FIGUEROA V M,CANDAL-RIVERA E,et al.Prevalences of hypertension,type 2 diabetes mellitus,and cardiovascular disease in a cohort of Puerto Ricans with non-alcoholic fatty liver disease[J].P R Health Sci J,2024,43(1):18-24.
[6] 中华中医药学会脾胃病分会.非酒精性脂肪性肝病中医诊疗指南(基层医生版)[J].中西医结合肝病杂志,2019,29(5):后插3-后插6.
[7] 国家卫生健康委员会疾病预防控制局.中国成人超重和肥胖预防控制指南-2021[M].北京:人民卫生出版社,2021.
[8] 王文,隋辉,陈伟伟.《中国高血压基层管理指南》要点解读[J].中国实用内科杂志,2015,35(4):317-319.
[9] 邱秀君,陈越,冯文才.药物服务干预对老年高血压患者的治疗及用药安全性的影响[J].广州医药,2023,54(12):49-54.
[10] USHIDA T,KOTANI T,KINOSHITA F,et al.Liver transaminase levels during pregnancy:A Japanese multicenter study[J].J Matern Fetal Neonatal Med,2022,35(25):5761-5767.
[11] 雷婷,刘洋,卜慧颖,等.健康体检人员脂肪肝检出率及相关危险因素分析[J].新疆医学,2023,53(12):1458-1461.
[12] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2020年版)(上)[J].中国实用内科杂志,2021,41(8):668-695.
[13] BORGHI C,DOMIENIK-KARŁOWICZ J,TYKARSKI A,et al.Expert consensus for the diagnosis and treatment of patient with hyperuricemia and high cardiovascular risk:2021 update[J].Cardiol J,2021,28(1):1-14.
[14] YOUNOSSI Z M,GOLABI P,PAIK J M,et al.The global epidemiology of nonalcoholic fatty liver disease(NAFLD)and nonalcoholic steatohepatitis(NASH):A systematic review[J].Hepatology,2023,77(4):1335-1347.
[15] KUNG M L,CHENG S M,WANG Y H,et al.Deficiency of ADAR2 ameliorates metabolic-associated fatty liver disease via AMPK signaling pathways in obese mice[J].Commun Biol,2024,7(1):594.
[16] 吴挺丰,廖献花,钟碧慧.中国部分地区非酒精性脂肪肝病的流行情况[J].临床肝胆病杂志,2020,36(6):1370-1373.
[17] 安晓兰. 脂肪肝和高血脂与性别及年龄的相关分析[J].甘肃科技,2018,34(24):156-157.
[18] 孔晓丽,王广宇,徐春军,等.男女两性脂肪肝患病率随年龄变化的特征性分析[J].胃肠病学和肝病学杂志,2014,23(9):1061-1065.
[19] LI L,LIU D W,YAN H Y,et al.Obesity is an independent risk factor for non-alcoholic fatty liver disease:Evidence from a meta-analysis of 21 cohort studies[J].Obes Rev,2016,17(6):510-519.
[20] 邓宗奎,植懿丹,林华玲,等.健康体检人群脂肪肝与高血糖、高血脂、肝功能异常关系的研究[J].中国疗养医学,2014,23(8):676-678.
[21] 莫石柯. 肝硬化合并糖尿病患者胰岛素抵抗与肝功能关系研究[J].中国实用医药,2021,16(11):105-107.
[22] 章雅南,刘奕婷.沈阳市健康体检人群非酒精性脂肪肝患病情况及影响因素[J].公共卫生与预防医学,2019,30(3):67-70.
[23] 陈明霞,王昌高,邓照军.定安县体检人群脂肪肝发生现状及影响因素[J].华南预防医学,2022,48(8):1017-1020.
[24] 孙海燕. 非酒精性脂肪肝患者血生化指标、饮食及行为特征研究[J].华南预防医学,2020,46(6):605-608.
[25] 刘俊莲. 血脂、血糖联合肝功能检验在非酒精性脂肪肝诊断中的应用价值分析[J].现代诊断与治疗,2021,32(10):1640-1641.
[26] LANASPA M A,SANCHEZ-LOZADA L G,CHOI Y J,et al.Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress:Potential role in fructose-dependent and-independent fatty liver[J].J Biol Chem,2012,287(48):40732-40744.

某净水公司职工脂肪肝检出情况及影响因素分析

Prevalence of fatty liver disease and influencing factors among employees in a water purification company

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	李燕君, 成艳玲, 凡伟, 温慧玲, 谭俊杰, 吴文华, 彭琼, 张丽仙. 早产儿语言-社会行为发育差异的回顾性研究[J]. 广州医药, 2024, 55(9): 1054-1059.
[2]	马苗苗, 陈飞. 危重产妇代理决策者的决策困境及影响因素分析[J]. 广州医药, 2024, 55(8): 907-912.
[3]	周倩, 尹龙燕, 邱恒, 邹俐爱. 广州某三甲医院脑梗死住院费用及其影响因素分析[J]. 广州医药, 2024, 55(8): 950-957.
[4]	陶丽, 文若兰, 范婷, 龚兰娟, 赖杏, 朱燕梅. 冠心病患者心脏康复参与意愿的调查分析[J]. 广州医药, 2024, 55(7): 723-729.
[5]	吕佳慧, 杨海燕, 申雅琳. 唐氏综合征血清学筛查风险值异常孕妇选择接受无创产前基因检测的影响因素及临床价值[J]. 广州医药, 2024, 55(6): 631-637.
[6]	海迪, 袁凤霞, 王婷. 80例产科监护室妊娠期糖尿病产妇泌乳启动延迟及影响因素分析[J]. 广州医药, 2024, 55(6): 638-642.
[7]	张亚楠, 张永灿. 脑出血患者家属参与治疗共享决策满意度现状及影响因素分析[J]. 广州医药, 2024, 55(5): 535-540.
[8]	郑桂花, 周志聪, 林桂永, 张晓红, 银孟卓. 养老机构老年人死亡态度及其影响因素研究[J]. 广州医药, 2024, 55(3): 274-278.
[9]	张萌, 高芳芳, 王俊博, 郑冬冬. 236例维持性血液透析患者的病耻感现状及影响因素分析[J]. 广州医药, 2024, 55(2): 132-136.
[10]	李娜, 戴玲, 蔡娟. 全麻髋关节置换术后苏醒期患者家属迁移应激水平及其相关影响因素分析[J]. 广州医药, 2024, 55(2): 141-145.
[11]	李春蕾, 郭凤枝, 郭玉生, 郭改梅, 郭洁. 80例局部宫颈癌根治性同步放化疗的临床疗效及预后影响因素[J]. 广州医药, 2024, 55(11): 1350-1356.
[12]	严晓芬, 王秋燕, 高翔. 广东省某三甲医院门诊老年患者补充与替代医学使用现状及影响因素分析[J]. 广州医药, 2023, 54(9): 84-89.
[13]	李东方. 心房颤动患者住院病死率的影响因素单中心研究[J]. 广州医药, 2023, 54(9): 98-102.
[14]	潘东妮, 盘丽华, 韦叙, 兰展, 韦萍. K点刺激联合吞咽-摄食管理下颅脑外伤术后吞咽障碍患者康复影响因素分析[J]. 广州医药, 2023, 54(7): 63-67.
[15]	陈文翰, 王亚克, 廖锋群, 王勇刚. 基于COX回归分析MHD尿毒症患者AVF使用寿命的独立危险因素[J]. 广州医药, 2023, 54(7): 93-98.